BioNTech SE ADR (BNTX) Social Stream



BioNTech SE ADR (BNTX): $90.61

2.37 (-2.55%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add BNTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#75 of 362

in industry

BIONTECH SE (BNTX) Price Targets From Analysts

Use the tables below to see what analysts covering BIONTECH SE think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 6 $450 $146 $275.666 $103.68 165.88%
2021-11-29 6 $450 $146 $278.666 $103.68 168.78%
2021-12-15 6 $450 $146 $279.555 $103.68 169.63%
2021-12-16 7 $450 $146 $281 $103.68 171.03%
2022-01-11 7 $450 $146 $281.6 $103.68 171.6%
2022-01-18 7 $450 $146 $280.6 $103.68 170.64%
2022-01-26 7 $450 $146 $274 $103.68 164.27%
2022-02-14 7 $450 $146 $267.3 $103.68 157.81%
2022-03-18 7 $450 $146 $264.6 $103.68 155.21%
2022-03-31 7 $450 $146 $262.1 $103.68 152.8%
2022-04-05 7 $339 $146 $247.1 $103.68 138.33%
2022-04-12 7 $339 $146 $245.1 $103.68 136.4%
2022-05-10 7 $300 $146 $240.7 $103.68 132.16%
2022-05-18 8 $350 $146 $250.636 $103.68 141.74%
2022-05-24 9 $350 $146 $246.916 $103.68 138.15%
2022-06-21 9 $350 $183 $256.09 $103.68 147%
2022-07-15 10 $350 $183 $240.7 $103.68 132.16%
2022-07-29 9 $350 $192 $247.222 $103.68 138.45%
2022-08-08 10 $350 $192 $247.222 $103.68 138.45%
2022-08-09 10 $350 $194 $246.444 $103.68 137.7%
2022-08-13 11 $350 $194 $245.222 $103.68 136.52%
2022-08-18 11 $350 $177 $233.363 $103.68 125.08%
2022-09-17 10 $350 $177 $226.7 $103.68 118.65%
2022-10-03 10 $350 $153 $224.3 $103.68 116.34%
2022-10-12 9 $350 $153 $224.3 $103.68 116.34%
2022-10-21 9 $350 $153 $224 $103.68 116.05%
2022-11-07 9 $350 $132 $218.9 $103.68 111.13%
2022-11-08 9 $350 $132 $216 $103.68 108.33%
2022-11-21 9 $350 $148 $217.6 $103.68 109.88%
2023-01-10 9 $350 $148 $217.6 $103.68 109.88%
2023-01-24 9 $350 $148 $218.9 $103.68 111.13%
2023-01-27 9 $350 $145 $218.1 $103.68 110.36%
2023-02-08 9 $350 $142 $215.4 $103.68 107.75%
2023-03-27 9 $350 $142 $206.888 $103.68 99.54%
2023-03-28 10 $350 $130 $196.444 $103.68 89.47%
2023-03-29 10 $350 $130 $192.444 $103.68 85.61%
2023-03-31 11 $350 $130 $184.545 $103.68 77.99%
2023-04-10 10 $213 $128 $166.6 $103.68 60.69%
2023-04-24 10 $213 $128 $165.3 $103.68 59.43%
2023-04-28 10 $210 $128 $163.7 $103.68 57.89%
2023-05-03 10 $210 $128 $162.6 $103.68 56.83%
2023-05-09 10 $210 $109 $157.9 $103.68 52.3%
2023-05-11 11 $210 $109 $158.636 $103.68 53.01%
2023-05-18 12 $210 $109 $155.416 $103.68 49.9%
2023-05-23 12 $203 $109 $155.615 $103.68 50.09%
2023-06-01 12 $203 $109 $154.307 $103.68 48.83%
2023-06-02 12 $203 $109 $154.461 $103.68 48.98%
2023-06-16 11 $203 $109 $156.416 $103.68 50.86%
2023-07-11 11 $203 $109 $156 $103.68 50.46%
2023-07-28 11 $203 $109 $153.538 $103.68 48.09%
2023-08-07 11 $203 $109 $153.23 $103.68 47.79%
2023-08-08 11 $200 $109 $153 $103.68 47.57%
2023-08-28 11 $200 $100 $149.923 $103.68 44.6%
2023-10-10 11 $200 $100 $150.153 $103.68 44.82%
2023-10-16 11 $200 $100 $148.692 $103.68 43.41%
2023-10-17 11 $200 $100 $148.23 $103.68 42.97%
2023-10-23 11 $200 $100 $142.692 $103.68 37.63%
2023-10-31 12 $200 $100 $140.071 $103.68 35.1%
2023-11-06 12 $200 $100 $140.142 $103.68 35.17%
2023-11-07 12 $200 $101 $140.285 $103.68 35.31%
2023-11-14 12 $200 $101 $133.153 $103.68 28.43%
2023-11-27 12 $200 $101 $129.846 $103.68 25.24%
2023-12-04 12 $200 $99 $129.307 $103.68 24.72%
2023-12-12 12 $200 $99 $129.384 $103.68 24.79%

The Trend in the Analyst Price Target


BNTX's average price target has moved up $45.13 over the prior 37 months.

BNTX reports an average of 45.25% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-08-28 11 200 100 149.923 120.68 24.23%
2023-10-10 11 200 100 150.153 111.17 35.07%
2023-10-23 11 200 100 142.692 92.52 54.23%
2023-11-06 12 200 100 140.142 99.71 40.55%
2023-11-14 12 200 101 135.785 100.66 34.89%

BNTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 5 0 6 1 1 12

The Trend in the Broker Recommendations


BNTX's average broker recommendation rating worsened by 0.13 over the prior 16 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • BIONTECH SE's average analyst price target is higher than 7061.6% of all US stocks.
  • In the context of stocks in the large market cap category, BIONTECH SE's upside potential (average analyst target price relative to current price) is greater than 6870.08% of them.
  • BIONTECH SE's variance in analysts' estimates is lower than -6342.6% of stocks in the large market cap category.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, BIONTECH SE's number of analysts covering the stock is greater than 2004.62% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIONTECH SE are MRNA, DNLI, and ARGX.

Is BNTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!